Cargando…
Management of Dyslipidemia in Type 2 Diabetes: Recent Advances in Nonstatin Treatment
Dyslipidemia is a major risk factor for cardiovascular disease (CVD), which is the leading cause of morbidity and mortality in type 2 diabetes (T2DM). Statins have played a crucial role in its management, but residual risk remains since many patients cannot achieve their desired low-density lipoprot...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023493/ https://www.ncbi.nlm.nih.gov/pubmed/29794992 http://dx.doi.org/10.3390/diseases6020044 |